“…Many efforts have been developed for automating lesion size measurement. Specifically, deep convolutional neural networks are successfully applied to segment tumors in brain [12], lung [31,16,39], pancreas [41,37], liver [8,19,7,22,28,36], enlarged lymph node [20,40], etc. Most of these approaches are specifically designed for a certain lesion type, however, an effective and efficient lesion size measurement tool should be able to handle a variety of lesions in practice [3,26,1,29].…”